Literature DB >> 19931448

Prognostic value of a three-grade classification in primary epithelial parotid carcinoma: result of a histological review from a 20-year experience of total parotidectomy with neck dissection in a single institution.

Elham Jouzdani1, Jacques Yachouh, Valérie Costes, Jean Luc Faillie, César Cartier, Flora Poizat, Guillemette Pierre, Vincent Burcia, Marc Makeieff, Louis Crampette, Bernard Guerrier, Renaud Garrel.   

Abstract

BACKGROUND: The tumour grading of primary parotid cancers (PPCs) remains controversial.
METHODS: A 20-year standardised single centre treatment has been assessed retrospectively. The histological review of 155 consecutively treated parotid malignancies identified 96 suitable cases for univariate and multivariate survival analyses.
RESULTS: Treatment involved total parotidectomy, neck dissection and post-operative radiotherapy in, respectively, 91.7%, 83.3% and 70.4% of cases. The 5-year overall survival, disease-specific and recurrence-free survival rates were 79.4%, 83.5% and 70.8%, respectively. Univariate analysis confirmed the classical prognostic factors, i.e. age>60 years, male gender, facial palsy, hardness of the tumour, clinical stage, tumour grade, facial nerve invasion and lymph node metastases. Multivariate analysis identified a three-grade classification just after the clinical stage as the most important prognostic factor.
CONCLUSION: This study identifies the prognostic significance of intermediate grade tumours. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 19931448     DOI: 10.1016/j.ejca.2009.10.012

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

1.  Overexpression of DCLK1 is predictive for recurrent disease in major salivary gland malignancies.

Authors:  Lorenz Kadletz; Klaus Aumayr; Gregor Heiduschka; Sven Schneider; Elisabeth Enzenhofer; Claudia Lill
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-28       Impact factor: 2.503

2.  [Salivary gland tumors: pathology and prognosis].

Authors:  S Schwarz-Furlan
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

3.  Clinicopathological analysis of salivary gland carcinomas and literature review.

Authors:  Hideo Shigeishi; Kouji Ohta; Gaku Okui; Sayaka Seino; Miho Hashikata; Kazuhiro Yamamoto; Yoko Ishida; Kazuki Sasaki; Takako Naruse; Mohammad Zeshaan Rahman; Ryo Uetsuki; Akiko Nimiya; Shigehiro Ono; Hiroshi Shimasue; Koichiro Higashikawa; Masaru Sugiyama; Masaaki Takechi
Journal:  Mol Clin Oncol       Date:  2014-10-09

4.  Retrospective Study of Cisplatin/Carboplatin, 5-Fluorouracil Plus Cetuximab (EXTREME) for Advanced-stage Salivary Gland Cancer.

Authors:  Takafumi Nakano; Ryuji Yasumatsu; Kazuki Hashimoto; Ryosuke Kuga; Takahiro Hongo; Hidetaka Yamamoto; Mioko Matsuo; Takahiro Wakasaki; Rina Jiromaru; Tomomi Manako; Satoshi Toh; Muneyuki Masuda; Moriyasu Yamauchi; Yuichiro Kuratomi; Hideoki Uryu; Torahiko Nakashima; Akihiro Tamae; Risa Tanaka; Masahiko Taura; Toranoshin Takeuchi; Takamasa Yoshida; Takashi Nakagawa
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

Review 5.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

6.  Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer.

Authors:  Tobias Ach; Katharina Zeitler; Stephan Schwarz-Furlan; Katharina Baader; Abbas Agaimy; Christian Rohrmeier; Johannes Zenk; Martin Gosau; Torsten E Reichert; Gero Brockhoff; Tobias Ettl
Journal:  Virchows Arch       Date:  2012-12-15       Impact factor: 4.064

7.  Clinicopathological Behavior and Oncological Outcomes of Malignant Parotid Tumors in a Pakistani Population.

Authors:  Muhammad Faisal; Taskheer Abbas; Mohammad Adeel; Usman Khaleeq; Abdul Wahid Anwer; Kashif Malik; Raza Hussain; Arif Jamshed
Journal:  Cureus       Date:  2018-02-05

8.  Clinical approach and treatment of benign and malignant parotid masses, personal experience.

Authors:  F Bussu; C Parrilla; D Rizzo; G Almadori; G Paludetti; J Galli
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-06       Impact factor: 2.124

9.  Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer.

Authors:  T Ettl; K Baader; C Stiegler; M Müller; A Agaimy; J Zenk; T Kühnel; M Gosau; K Zeitler; S Schwarz; G Brockhoff
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640

10.  Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma.

Authors:  Yukio Watabe; Taisuke Mori; Seiichi Yoshimoto; Takeshi Nomura; Takahiko Shibahara; Tesshi Yamada; Kazufumi Honda
Journal:  Cancer Med       Date:  2014-02-27       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.